StonvexLoading…
StonvexStonvexStonvexCore line items from AGCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.08B | $11.66B | $14.41B | $12.65B |
Operating Income | $595.70M | $-122.10M | $1.70B | $1.27B |
Net Income | $726.50M | $-424.80M | $1.17B | $889.60M |
EPS (Diluted) | $9.75 | $-5.69 | $15.63 | $11.87 |
Total Assets | $11.93B | $11.19B | $11.42B | $10.10B |
Total Liabilities | $7.36B | $7.15B | $6.76B | $6.22B |
Cash & Equivalents | $861.80M | $612.70M | $595.50M | $789.50M |
Free Cash Flow OCF − CapEx | $740.20M | $296.60M | $585.00M | $449.90M |
Shares Outstanding | 72.63M | 74.42M | 74.52M | 74.60M |